Purification and identification of a BMP-like factor from bovine serum

Biochemical and Biophysical Research Communications

Volumn 345, Issue 3, 2006, Pages 1224-1231

  Kodaira, Kunihiko ^a,b   Imada, Mana ^c   Goto, Masaaki ^a,b   Tomoyasu, Akihiro ^a,b   Fukuda, Toru ^a   Kamijo, Ryutaro ^c   Suda, Tatsuo ^a   Higashio, Kanji ^a,b   Katagiri, Takenobu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic proteins; Liquid chromatography tandem mass spectrometry; Myogenesis; Osteoblasts; Serum

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL MATURATION; COMPLEX FORMATION; CONTROLLED STUDY; COW; EMBRYO; FETAL BOVINE SERUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MOLECULAR WEIGHT; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; OSTEOBLAST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PURIFICATION; SERUM; SPECIES COMPARISON; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CATTLE; CELL DIFFERENTIATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; SIGNAL TRANSDUCTION;

BOS TAURUS; MURINAE;

EID: 33646836242     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.045     Document Type: Article

References (35)

1. Spizz G., Roman D., Strauss A., and Olson E.N. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. J. Biol. Chem. 261 (1986) 9483-9488
2. Whitman M., and Mercola M. TGF-β superfamily signaling and left-right asymmetry. Sci. STKE 2001 (2001) RE1
3. Roelen B.A., and Dijke P. Controlling mesenchymal stem cell differentiation by TGFβ family members. J. Orthop. Sci. 8 (2003) 740-748
4. Walsh F.S., and Celeste A.J. Myostatin: a modulator of skeletal-muscle stem cells. Biochem. Soc. Trans. 33 (2005) 1513-1517
5. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899
6. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., and Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
7. Thomas J.T., Kilpatrick M.W., Lin K., Erlacher L., Lembessis P., Costa T., Tsipouras P., and Luyten F.P. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat. Genet. 17 (1997) 58-64
8. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127 (1994) 1755-1766
9. Katagiri T., Akiyama S., Namiki M., Komaki M., Yamaguchi A., Rosen V., Wozney J.M., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Exp. Cell Res. 230 (1997) 342-351
10. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., Kahn A.J., Suda T., and Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113 (1991) 681-687
11. Katagiri T., and Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 8 (2002) 147-159
12. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16 (2005) 251-263
13. Massague J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev. 19 (2005) 2783-2810
14. Namiki M., Akiyama S., Katagiri T., Suzuki A., Ueno N., Yamaji N., Rosen V., Wozney J.M., and Suda T. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J. Biol. Chem. 272 (1997) 22046-22052
15. Yamamoto N., Akiyama S., Katagiri T., Namiki M., Kurokawa T., and Suda T. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem. Biophys. Res. Commun. 238 (1997) 574-580
16. Fujii M., Takeda K., Imamura T., Aoki H., Sampath T.K., Enomoto S., Kawabata M., Kato M., Ichijo H., and Miyazono K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10 (1999) 3801-3813
17. Korchynskyi O., and ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277 (2002) 4883-4891
18. Katagiri T., Imada M., Yanai T., Suda T., Takahashi N., and Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7 (2002) 949-960
19. Lopez-Rovira T., Chalaux E., Massague J., Rosa J.L., and Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277 (2002) 3176-3185
20. Gonzalez-Cadavid N.F., Taylor W.E., Yarasheski K., Sinha-Hikim I., Ma K., Ezzat S., Shen R., Lalani R., Asa S., Mamita M., Nair G., Arver S., and Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc. Natl. Acad. Sci. USA 95 (1998) 14938-14943
21. Wolfman N.M., McPherron A.C., Pappano W.N., Davies M.V., Song K., Tomkinson K.N., Wright J.F., Zhao L., Sebald S.M., Greenspan D.S., and Lee S.J. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc. Natl. Acad. Sci. USA 100 (2003) 15842-15846
22. Bogdanovich S., Krag T.O., Barton E.R., Morris L.D., Whittemore L.A., Ahima R.S., and Khurana T.S. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420 (2002) 418-421
23. Chen C., Grzegorzewski K.J., Barash S., Zhao Q., Schneider H., Wang Q., Singh M., Pukac L., Bell A.C., Duan R., Coleman T., Duttaroy A., Cheng S., Hirsch J., Zhang L., Lazard Y., Fischer C., Barber M.C., Ma Z.D., Zhang Y.Q., Reavey P., Zhong L., Teng B., Sanyal I., Ruben S.M., Blondel O., and Birse C.E. An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat. Biotechnol. 21 (2003) 294-301
24. Bader D., Masaki T., and Fischman D.A. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95 (1982) 763-770
25. Akiyama S., Katagiri T., Namiki M., Yamaji N., Yamamoto N., Miyama K., Shibuya H., Ueno N., Wozney J.M., and Suda T. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp. Cell Res. 235 (1997) 362-369
26. Zimmerman L.B., De Jesus-Escobar J.M., and Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86 (1996) 599-606
27. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., and ten Dijke P. Identification of Smad7, a TGFβ-inducible antagonist of TGF-beta signalling. Nature 389 (1997) 631-635
28. Aono A., Hazama M., Notoya K., Taketomi S., Yamasaki H., Tsukuda R., Sasaki S., and Fujisawa Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem. Biophys. Res. Commun. 210 (1995) 670-677
29. Suzuki A., Kaneko E., Maeda J., and Ueno N. Mesoderm induction by BMP-4 and -7 heterodimers. Biochem. Biophys. Res. Commun. 232 (1997) 153-156
30. Takada T., Katagiri T., Ifuku M., Morimura N., Kobayashi M., Hasegawa K., Ogamo A., and Kamijo R. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278 (2003) 43229-43235
31. Hollnagel A., Oehlmann V., Heymer J., Ruther U., and Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274 (1999) 19838-19845
32. Tournay O., and Benezra R. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol. Cell. Biol. 16 (1996) 2418-2430
33. Ogata T., Wozney J.M., Benezra R., and Noda M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc. Natl. Acad. Sci. USA 90 (1993) 9219-9222
34. Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C., and Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 16 (1996) 3545-3553
35. Ying Q.L., Nichols J., Chambers I., and Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115 (2003) 281-292